Advertisement

Experimental Brain Research

, Volume 236, Issue 3, pp 655–664 | Cite as

Circadian dysfunction and fluctuations in gait initiation impairment in Parkinson’s disease

  • Julianne Stewart
  • Gail Bachman
  • Clarissa Cooper
  • Lianqi Liu
  • Sonia Ancoli-Israel
  • Laila AlibiglouEmail author
Research Article

Abstract

In people with Parkinson’s disease (PD), anticipatory postural adjustments may be prolonged, reduced in amplitude, or absent, contributing to impaired gait initiation. In addition to motor symptoms, disturbance of the circadian rhythm (CR) is one of the common non-motor symptoms of PD. The purpose of this study was to investigate whether time of day modulates the magnitude of gait initiation impairment, and furthermore, if there is any relationship between CR dysfunction and impaired postural control in PD. Seven consecutive 24-h periods of wrist actigraphy (as a measure of CR), and then gait initiation studies (at two different times, 9:00 a.m. and 2:30 p.m., of the same day) were conducted in two cohorts of ten subjects each: people with PD, and age-matched control subjects. We found that in the PD group, the amplitude of medial/lateral center of pressure (CoP) excursions were significantly reduced in the afternoon as compared with the morning session across all trials (p < 0.05). Actigraphy results showed that CR amplitude was significantly decreased (p < 0.05) in the PD group, which suggests that the PD group suffered from CR disruption. More importantly, changes in medial/lateral CoP displacement were correlated with abnormal CR amplitude in the PD group. These findings provide novel evidence that diurnal fluctuations in treatment-resistant motor symptoms of PD, such as postural and gait initiation deficits, are associated with CR dysfunction. This study supports the idea that therapeutic correction of circadian misalignment should be considered in combination with pharmaceutical and rehabilitation treatments of motor symptoms in PD.

Keywords

Parkinson’s disease Circadian rhythm Gait disorders Postural control Actigraphy 

Notes

Acknowledgements

We would like to thank Farzana Boman for her invaluable contribution in recruiting subjects, data collection and analysis; Siddhi Tavildar and Thomas Ruopp for their significant help in creating and developing the data analysis programs, the study participants for their time, and the Parkinson’s Association of San Diego for their support in recruiting volunteers with PD.

Compliance with ethical standards

Funding

Dr. Liu and Dr. Ancoli-Israel received grant support from the NIH (UL1RR031980) and NIA (AG08415).

Conflict of interest

The authors have no conflicts of interest to disclose.

References

  1. Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S (2010) Melatonin MT1 and MT2 receptor expression in Parkinson’s disease. Med Sci Monit 16(2):BR61–BR67PubMedGoogle Scholar
  2. Alibiglou L, Videnovic A, Planetta PJ, Vaillancourt DE, MacKinnon CD (2016) Subliminal gait initiation deficits in REM sleep behavior disorder: a harbinger of freezing of gait? Mov Disord 31(11):1711–1719CrossRefPubMedPubMedCentralGoogle Scholar
  3. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP (2003) The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26(3):342–392CrossRefPubMedGoogle Scholar
  4. Apps MCP, Sheaff PC, Ingram DA, Kennard C, Empey DW (1985) Respiration and sleep in Parkinson’s disease. J Neurol Neurosurg Psychiatry 48:1240–1245CrossRefPubMedPubMedCentralGoogle Scholar
  5. Aston-Jones G, Bloom FE (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep–waking cycle. J Neurosci 1(8):876–886PubMedGoogle Scholar
  6. Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649CrossRefPubMedGoogle Scholar
  7. Bergozoni P, Chiurulla C, Gambi D, Mennuni G, Pinto F (1975) L-dopa plus dopadecarboxylase inhibitor: sleep organization in Parkinson’s syndrome before and after treatment. Acta Neurol Belg 75:5–10Google Scholar
  8. Bradbury AJ, Kelly ME, Smith JA (1985) Melatonin action in the midbrain can regulate forebrain dopamine function both behaviorally and biochemically. In: Brown GM, Wainright SD (eds) Advances in the biosciences: the Pineal gland: endocrine aspects, vol 53. Pergamon Press, Oxford, pp 327–332Google Scholar
  9. Daley J, Turner R, Bliwise D, Rye D (1999) Nocturnal sleep and daytime alertness in the MPTP-treated primate. Sleep 22(Suppl):S218–S219Google Scholar
  10. Delval A, Tard C, Defebvre L (2014) Why we should study gait initiation in Parkinson’s disease. Neurophysiol Clin 44:69–76CrossRefPubMedGoogle Scholar
  11. Dhawan V, Healy DG, Pal S, Chaudhuri KR (2006) Sleep-related problems of Parkinson’s disease. Age Ageing 35(3):220–228CrossRefPubMedGoogle Scholar
  12. Dzirasa K, Ribeiro S, Costa R et al (2006) Dopaminergic control of sleep–wake states. J Neurosci 26(4):10577–10589CrossRefPubMedGoogle Scholar
  13. Frank JS, Horak FB, Nutt J (2000) Centrally initiated postural adjustments in parkinsonian patients on and off levodopa. J Neurophysiol 84:2440–2448CrossRefPubMedGoogle Scholar
  14. Freeman A, Ciliax B, Bakay R, Daley J, Miller RD, Keating G, Levey A, Rye D (2001) Nigrostriatal collaterals to thalamus degenerate in Parkinsonian animal models. Ann Neurol 50(3):321–329CrossRefPubMedGoogle Scholar
  15. Fuller PM, Gooley JJ, Saper CB (2006) Neurobiology of the sleep–wake cycle: sleep architecture, circadian regulation, and regulatory feedback. J Biol Rhythms 21(6):482–493CrossRefPubMedGoogle Scholar
  16. Gantchev N, Viallet F, Aurenty R, Massion J (1996) Impairment of posturo-kinetic co-ordination during initiation of forward oriented stepping movements in parkinsonian patients. Electroencephalogr Clin Neurophysiol 101(2):110–120CrossRefPubMedGoogle Scholar
  17. Giladi N, McMahon D, Przedborski S, Flaster E, Guillory S, Kostic V, Fahn S (1992) Motor blocks in Parkinson’s disease. Neurology 42:333–339CrossRefPubMedGoogle Scholar
  18. Golombek DA, Rosenstein RE (2010) Physiology of circadian entrainment. Physiol Rev 90:1063–1102CrossRefPubMedGoogle Scholar
  19. Grimbergen YA, Langston JW, Roos RA, Bloem BR (2009) Postural instability in Parkinson’s disease: the adrenergic hypothesis and locus coeruleus. Expert Rev Neurother 9(2):279–290CrossRefPubMedGoogle Scholar
  20. Hall LM, Brauer SG, Horak F, Hodges PW (2013) The effect of Parkinson’s disease and Levodopa on adaptation of anticipatory postural adjustments. Neuroscience 250:483–492CrossRefPubMedGoogle Scholar
  21. Hass CJ, Waddell DE, Fleming RP, Juncos JL, Gregor RJ (2005) Gait initiation and dynamic balance control in Parkinson’s disease. Arch Phys Med Rehabil 86:2172–2176CrossRefPubMedGoogle Scholar
  22. Heckman CJ, Lee RH, Brownstone RM (2003) Hyperexcitable dendrites in motoneurons and their neuromodulatory control during motor behavior. Trends Neurosci 26:688–695CrossRefPubMedGoogle Scholar
  23. Heckman CJ, Mottram C, Quinlan K, Theiss R, Schuster J (2009) Motoneuron excitability: the importance of neuromodulatory inputs. Clin Neurophysiol 120(12):2040–2054CrossRefPubMedGoogle Scholar
  24. Hood S, Cassidy P, Cossette MP, Weigl Y, Verwey M, Robinson B, Stewart J, Amir S (2010) Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci 30(42):14046–14058CrossRefPubMedGoogle Scholar
  25. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRefPubMedPubMedCentralGoogle Scholar
  26. Hultborn H, Brownstone RB, Toth TI, Gossard JP (2004) Key mechanisms for setting the input–output gain across the motoneuron pool. Prog Brain Res 143:77–95PubMedGoogle Scholar
  27. Imbesi M, Yildiz S, Dirim Arslan A, Sharma R, Manev H, Uz T (2009) Dopamine receptor-mediated regulation of neuronal “clock” gene expression. Neuroscience 158(2):537–544CrossRefPubMedGoogle Scholar
  28. Inouye ST, Kawamura H (1979) Persistence of circadian rhythmicity in a mammalian hypothalamic “island” containing the suprachiasmatic nucleus. Proc Natl Acad Sci USA 76(11):5962–5966CrossRefPubMedPubMedCentralGoogle Scholar
  29. Kales A, Ansel RD, Markham CH, Scharf MB, Tan TL (1971) Sleep in patients with Parkinson’s disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 12(2):397–407CrossRefPubMedGoogle Scholar
  30. Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP (2006) Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev 20(14):1868–1873CrossRefPubMedPubMedCentralGoogle Scholar
  31. Kudo T, Loh DH, Truong D, Wu Y, Colwell CS (2011) Circadian dysfunction in a mouse model of Parkinson’s disease. Exp Neurol 232(1):66–75CrossRefPubMedGoogle Scholar
  32. Kumar S, Bhatia M, Behari M (2002) Sleep disorders in Parkinson’s disease. Mov Disord 17(4):775–781CrossRefPubMedGoogle Scholar
  33. Lauretti E, Di Meco A, Merali S, Praticò D (2017) Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson’s disease. Mol Psychiatry 22(2):280–286CrossRefPubMedGoogle Scholar
  34. Lees AJ, Blackburn NA, Campbell VL (1988) The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 11(6):512–519CrossRefPubMedGoogle Scholar
  35. Littner M, Kushida CA, Anderson WM et al (2003) Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep 26(3):337–341CrossRefPubMedGoogle Scholar
  36. Lou JS (2009) Physical and mental fatigue in Parkinson’s disease: epidemiology, pathophysiology and treatment. Drugs Aging 26(3):195–208CrossRefPubMedGoogle Scholar
  37. MacKinnon CD, Bissig D, Chiusano J, Miller E, Rudnick L, Jager C, Zhang Y, Mille ML, Rogers MW (2007) Preparation of anticipatory postural adjustments prior to stepping. J Neurophysiol 97(6):4368–4379CrossRefPubMedGoogle Scholar
  38. Maglione JE, Liu L, Neikrug AB et al (2013) Actigraphy for the assessment of sleep measures in Parkinson’s disease. Sleep 36(8):1209–1217CrossRefPubMedPubMedCentralGoogle Scholar
  39. Marler MR, Gehrman P, Martin JL, Ancoli-Israel S (2006) The sigmoidally transformed cosine curve: a mathematical model for circadian rhythms with symmetric non-sinusoidal shapes. Stat Med 25(22):3893–3904CrossRefPubMedGoogle Scholar
  40. Mille ML, Hilliard MJ, Martinez KM, Simuni T, Rogers MW (2007) Acute effects of lateral postural assist on voluntary step initiation in patients with Parkinson’s disease. Mov Disord 22(1):20–27CrossRefPubMedGoogle Scholar
  41. Miller JD, Farber J, Gatz P, Roffwarg H, German DC (1983) Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Res 273(1):133–141CrossRefPubMedGoogle Scholar
  42. Morris ME, Iansek R, Matyas TA, Summers JJ (1996) Stride length regulation in Parkinson’s disease. Normalization strategies and underlying mechanisms. Brain 119:551–568CrossRefPubMedGoogle Scholar
  43. Oken BS, Salinsky MC, Elsas SM (2006) Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol 117:1885–1901CrossRefPubMedPubMedCentralGoogle Scholar
  44. Pahapill PA, Lozano AM (2000) The pedunculopontine nucleus and Parkinson’s disease. Brain 123(9):1767–1783CrossRefPubMedGoogle Scholar
  45. Pogarell O, Gasser T, van Hilten JJ, Spieker S, Pollentier S, Meier D, Oertel WH (2002) Pramipexole in patients with Parkinson’s disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study. Neurol Neurosurg Psychiatry 72:713–720CrossRefGoogle Scholar
  46. Ralph MR, Foster RG, Davis FC, Menaker M (1990) Transplanted suprachiasmatic nucleus determines circadian period. Science 247(4945):975–978CrossRefPubMedGoogle Scholar
  47. Rogers MW, Kennedy R, Palmer S, Pawar M, Reising M, Martinez KM, Simuni T, Zhang Y, MacKinnon CD (2011) Postural preparation prior to stepping in patients with Parkinson’s disease. J Neurophysiol 106(2):915–924CrossRefPubMedGoogle Scholar
  48. Rutten S, Vriend C, van den Heuvel OA, Smit JH, Berendse HW, van der Werf YD (2012) Bright light therapy in Parkinson’s disease: an overview of the background and evidence. Parkinsons Dis 2012:767105PubMedPubMedCentralGoogle Scholar
  49. Rye DB (2004) Parkinson’s disease and RLS: the dopaminergic bridge. Sleep Med 5(3):317–328CrossRefPubMedGoogle Scholar
  50. Saper CB, Chou TC, Scammell TE (2001) The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 24(12):726–731CrossRefPubMedGoogle Scholar
  51. Saper CB, Scammell TE, Lu J (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature 437(7063):1257–1263CrossRefPubMedGoogle Scholar
  52. Schrag A, Quinn N (2000) Dyskinesias and motor fluctuations in Parkinson’s disease: a community-based study. Brain 123:2297–2305CrossRefPubMedGoogle Scholar
  53. Steinfels GF, Heym J, Strecker RE, Jacobs BL (1983) Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res 258(2):217–228CrossRefPubMedGoogle Scholar
  54. Stephan FK, Zucker I (1972) Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Nat Acad Sci USA 69(6):1583–1586CrossRefPubMedPubMedCentralGoogle Scholar
  55. Stocchi F, Barbato L, Nordera G, Berardelli A, Ruggieri S (1998) Sleep disorders in Parkinson’s disease. J Neurol 245(S1):S15–S18CrossRefPubMedGoogle Scholar
  56. Tandberg E, Larsen JP, Karlsen K (1998) A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 13(6):895–899CrossRefPubMedGoogle Scholar
  57. Videnovic A, Willis GL (2016) Circadian system—a novel diagnostic and therapeutic target in Parkinson’s disease? Mov Disord 31(3):260–269CrossRefPubMedPubMedCentralGoogle Scholar
  58. Videnovic A, Noble C, Reid KJ et al (2014) Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol 71(4):463–469CrossRefPubMedPubMedCentralGoogle Scholar
  59. Wetter TC, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep 23(3):361–367CrossRefPubMedGoogle Scholar
  60. Whitehead DL, Davies AD, Playfer JR, Turnbull CJ (2008) Circadian rest-activity rhythm is altered in Parkinson’s disease patients with hallucinations. Mov Disord 23(8):1137–1145CrossRefPubMedGoogle Scholar
  61. Willis GL (2008) Parkinson’s disease as a neuroendocrine disorder of circadian function: dopamine–melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev Neurosci 19(4–5):245–316PubMedGoogle Scholar
  62. Willison LD, Kudo T, Loh DH, Kuljis D, Colwell CS (2013) Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson’s disease: insights from a transgenic mouse model. Exp Neurol 243:57–66CrossRefPubMedPubMedCentralGoogle Scholar
  63. Youngstedt SD, Kripke DF, Elliott JA, Klauber MR (2001) Circadian abnormalities in older adults. J Pineal Res 31(3):264–272CrossRefPubMedGoogle Scholar
  64. Zagmutt FJ, Tarrants ML (2012) Indirect comparisons of adverse events and dropout rates in early Parkinson’s disease trials of Pramipexole, Ropinirole, and Rasagiline. Int J Neurosci 122(7):345–353CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Julianne Stewart
    • 1
  • Gail Bachman
    • 1
  • Clarissa Cooper
    • 1
  • Lianqi Liu
    • 2
  • Sonia Ancoli-Israel
    • 2
  • Laila Alibiglou
    • 3
    • 4
    Email author
  1. 1.Doctor of Physical Therapy ProgramSan Diego State UniversitySan DiegoUSA
  2. 2.Department of PsychiatryUniversity of CaliforniaLa JollaUSA
  3. 3.Department of Physical TherapyRosalind Franklin University of Medicine and ScienceNorth ChicagoUSA
  4. 4.Department of NeuroscienceRosalind Franklin University of Medicine and ScienceNorth ChicagoUSA

Personalised recommendations